Skip to main content

Table 6 Risks (incidence rate ratio) of infant mortality and hospital admission in PREGACT study

From: Artemisinin-based combination therapy during pregnancy: outcome of pregnancy and infant mortality: a cohort study

 

IRR

95% CI

p-value

Infant mortality

 AL

1

–

0.96

 ASAQ

0.96

0.44–2.09

 

 MQAS

0.94

0.47–1.86

 

 DHAPQ

1.12

0.57–2.20

 

 Congenital anaemia

2.93

0.96–8.96

0.06

 Low birth weight

1.78

1.03–3.06

0.04

 Birth asphyxia

10.89

4.48–26.46

< 0.01

 Congenital abnormality

25.47

10.46–62.02

< 0.01

 Burkina Faso

1

–

< 0.01

 Ghana

1.02

0.31–3.36

 

 Malawi

2.14

0.89–5.15

 

 Zambia

4.02

1.85–8.73

 

Hospital admission

 AL

1

–

0.91

 ASAQ

1.01

0.71–1.43

 

 MQAS

0.88

0.57–1.35

 

 DHAPQ

1.01

0.70–1.47

 

 Baby ITN use

0.36

0.21–0.62

< 0.01

 Born at home

1.44

1.02–2.03

0.04

 Congenital malaria

3.80

0.93–15.56

0.06

 Congenital abnormality

5.12

2.09–12.51

< 0.01

 Burkina Faso

1

–

< 0.01

 Ghana

1.02

0.68–1.54

 

 Malawi

1.89

1.33–2.69

 

 Zambia

0.49

0.31–0.79

 
  1. IRR incidence rate ratio